Imre Noth
University of Virginia
215 Papers
259 Citations
Imre Noth is an academic researcher from University of Virginia. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 43, co-authored 162 publications. Previous affiliations of Imre Noth include University of Illinois at Chicago & Yale University.
Chat about Author
Papers
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Aryeh Fischer,Katerina M. Antoniou,Kevin K. Brown,Jacques Cadranel,Tamera J. Corte,Roland M. du Bois,Joyce S. Lee,Kevin O. Leslie,David A. Lynch,Eric L. Matteson,Marta Mosca,Imre Noth,Luca Richeldi,Mary E. Strek,Jeffrey J. Swigris,Athol U. Wells,Sterling G. West,Harold R. Collard,Vincent Cottin +18 more
TL;DR: A sound platform has been provided from which to launch the requisite future research investigations of a more uniform cohort, and nomenclature and classification criteria for patients with IIP and autoimmune features are provided.
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Imre Noth,Yingze Zhang,Shwu Fan Ma,Carlos Flores,Mathew Barber,Yong Huang,Steven M. Broderick,Michael S. Wade,Pirro G. Hysi,Joseph Scuirba,Thomas J. Richards,Brenda Juan-Guardela,Rekha Vij,MeiLan K. Han,Fernando J. Martinez,Karl Kossen,Scott D. Seiwert,Jason D. Christie,Dan L. Nicolae,Naftali Kaminski,Joe G.N. Garcia +20 more
TL;DR: A three-stage genome-wide association study to identify additional common variants associated with susceptibility and ultimately mortality in Idiopathic pulmonary fibrosis and novel variants in TOLLIP and SPPL2C are associated with IPF susceptibility.
586
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study
Philip C Haycock,Stephen Burgess,Aayah Nounu,Jie Zheng,G N Okoli,Jack Bowden,Kaitlin H Wade,Nicholas J. Timpson,David M. Evans,Peter Willeit,Abraham Aviv,Tom R. Gaunt,Gibran Hemani,Massimo Mangino,Hayley P Ellis,Kathreena M Kurian,Karen A. Pooley,Rosalind A. Eeles,Jeffrey E. Lee,Shenying Fang,Wei V. Chen,Matthew Law,Lisa Bowdler,Mark M. Iles,Qiong Yang,Bradford B. Worrall,Hugh S. Markus,Rayjean J. Hung,Christopher I. Amos,Amanda B. Spurdle,Deborah J. Thompson,Tracy A. O'Mara,Brian M. Wolpin,Laufey T. Amundadottir,Rachael Z. Stolzenberg-Solomon,Antonia Trichopoulou,N. Charlotte Onland-Moret,Eiliv Lund,Eric J. Duell,Federico Canzian,Gianluca Severi,Kim Overvad,Marc J. Gunter,Rosario Tumino,Ulrika Svenson,Andre M. van Rij,Annette F. Baas,Matthew J. Bown,Nilesh J. Samani,Femke N G van t'Hof,Gerard Tromp,Gregory T. Jones,Helena Kuivaniemi,James R. Elmore,Mattias Johansson,James McKay,Ghislaine Scelo,Robert Carreras-Torres,Valerie Gaborieau,Paul Brennan,Paige M. Bracci,Rachel E. Neale,Sara H. Olson,Steven Gallinger,Donghui Li,Gloria M. Petersen,Harvey A. Risch,Alison P. Klein,Jiali Han,Christian C. Abnet,Neal D. Freedman,Philip R. Taylor,John M. Maris,Katja K.H. Aben,Lambertus A. Kiemeney,Sita H. Vermeulen,John K. Wiencke,Kyle M. Walsh,Margaret Wrensch,Terri Rice,Clare Turnbull,Kevin Litchfield,Lavinia Paternoster,Marie Standl,Gonçalo R. Abecasis,John Paul SanGiovanni,Yong Li,Vladan Mijatovic,Yadav Sapkota,Siew-Kee Low,Krina T. Zondervan,Grant W. Montgomery,Dale R. Nyholt,David A. van Heel,Karen A. Hunt,Dan E. Arking,Foram N. Ashar,Nona Sotoodehnia,Daniel Woo,Jonathan Rosand,Mary E. Comeau,W. Mark Brown,Edwin K. Silverman,John E. Hokanson,Michael H. Cho,Jennie Hui,Manuel A. R. Ferreira,Philip J. Thompson,Alanna C. Morrison,Janine F. Felix,Nicholas L. Smith,Angela M. Christiano,Lynn Petukhova,Regina C. Betz,Xing Fan,Xuejun Zhang,Caihong Zhu,Carl D. Langefeld,Susan D. Thompson,Feijie Wang,Xu Lin,David A. Schwartz,Tasha E. Fingerlin,Jerome I. Rotter,Mary Frances Cotch,Richard A. Jensen,Matthias Munz,Henrik Dommisch,Arne S. Schaefer,Fang Han,Hanna Ollila,Ryan P. Hillary,Omar M. E. Albagha,Stuart H. Ralston,Chenjie Zeng,Wei Zheng,Xiao-Ou Shu,André Reis,Steffen Uebe,Ulrike Hüffmeier,Yoshiya Kawamura,Takeshi Otowa,Tsukasa Sasaki,Martin L. Hibberd,Sonia Davila,Gang Xie,Katherine A. Siminovitch,Jin-Xin Bei,Yi Xin Zeng,Asta Försti,Bowang Chen,Stefano Landi,Andre Franke,Annegret Fischer,David Ellinghaus,Carlos Flores,Imre Noth,Shwu-Fan Ma,Jia Nee Foo,Jianjun Liu,Jong-Won Kim,David G. Cox,Olivier Delattre,Olivier Mirabeau,Christine F. Skibola,Clara S. Tang,Merce Garcia-Barcelo,Kai-Ping Chang,Wen-Hui Su,Yu-Sun Chang,Nicholas G. Martin,Scott D. Gordon,Tracey D. Wade,Chaeyoung Lee,Michiaki Kubo,Pei-Chieng Cha,Yusuke Nakamura,Daniel Levy,Masayuki Kimura,Shih-Jen Hwang,Steven C. Hunt,Tim D. Spector,Nicole Soranzo,Ani Manichaikul,R. Graham Barr,Bratati Kahali,Elizabeth K. Speliotes,Laura M. Yerges-Armstrong,Ching-Yu Cheng,Jost B. Jonas,Tien Yin Wong,Isabella Fogh,Kuang Lin,John Powell,Kenneth Rice,Caroline L Relton,Richard M. Martin,George Davey Smith +197 more
TL;DR: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases, as well as single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population.
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth,Kevin J. Anstrom,Sara B. Calvert,Joao A. de Andrade,Kevin R. Flaherty,Craig S. Glazer,Robert J. Kaner,Mitchell A. Olman +7 more
TL;DR: Treatment with warfarin was associated with an increased risk of mortality in an IPF population who lacked other indications for anticoagulation and was recommended to stop after 145 of the planned 256 subjects were enrolled.
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto,Yingze Zhang,Tasha E. Fingerlin,Shwu-Fan Ma,Joe G.N. Garcia,Thomas J. Richards,Lori J. Silveira,Kathleen O. Lindell,Mark P. Steele,James E. Loyd,Kevin F. Gibson,Max A. Seibold,Kevin K. Brown,Janet Talbert,Cheryl Markin,Karl Kossen,Scott D. Seiwert,Elissa Murphy,Imre Noth,Marvin I. Schwarz,Naftali Kaminski,David A. Schwartz +21 more
TL;DR: Whether the MUC5B promoter polymorphism (rs35705950), previously reported to be associated with the development of pulmonary fibrosis, is associated with survival in IPF is investigated to determine.